Singapore, Dec. 16 -- Singapore-basedZuellig Pharma, a leading healthcare solutions company in Asia, has expanded its partnership with H. Lundbeck A/S, a biopharmaceutical company focusing exclusively on brain health.Under this new agreement, Zuellig Pharma will take on the role of agency partner to commercialise Lundbeck's portfolio of products - including leading brands such as Lexapro(R), Brintellix(R)and Cipralex(R)- across Indonesia, Malaysia, the Philippines and Singapore. This builds on its existing distribution agreement with Lundbeck, under which Zuellig Pharma has been responsible for distributing the company's products in the four markets. In addition, Zuellig Pharma will also partner with Lundbeck in Taiwan.As part of the expa...